Cargando…

Novel phytochemical–antibiotic conjugates as multitarget inhibitors of Pseudomononas aeruginosa GyrB/ParE and DHFR

BACKGROUND: There is a dearth of treatment options for community-acquired and nosocomial Pseudomonas infections due to several rapidly emerging multidrug resistant phenotypes, which show resistance even to combination therapy. As an alternative, developing selective promiscuous hybrid compounds for...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jayaraman, Premkumar, Sakharkar, Kishore R, Lim, ChuSing, Siddiqi, Mohammad Imran, Dhillon, Sarinder K, Sakharkar, Meena K
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2013
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3692347/ https://www.ncbi.nlm.nih.gov/pubmed/23818757 http://dx.doi.org/10.2147/DDDT.S43964

Ejemplares similares

Hotspots sequences of gyrA, gyrB, parC, and parE genes encoded for fluoroquinolones resistance from local Salmonella Typhi strains in Jakarta
por: Nathania, Ignes, et al.
Publicado: (2022)

Discovery and druggability evaluation of pyrrolamide-type GyrB/ParE inhibitor against drug-resistant bacterial infection
por: Zhao, Xintong, et al.
Publicado: (2023)

Tricyclic GyrB/ParE (TriBE) Inhibitors: A New Class of Broad-Spectrum Dual-Targeting Antibacterial Agents
por: Tari, Leslie W., et al.
Publicado: (2013)

Discovery of seven novel mutations of gyrB, parC and parE in Salmonella Typhi and Paratyphi strains from Jiangsu Province of China
por: Qian, Huimin, et al.
Publicado: (2020)

Activity and interactions of antibiotic and phytochemical combinations against Pseudomonas aeruginosa in vitro
por: Jayaraman, Premkumar, et al.
Publicado: (2010)

A Novel Oral GyrB/ParE Dual Binding Inhibitor Effective against Multidrug-Resistant Neisseria gonorrhoeae and Other High-Threat Pathogens
por: Park, Steven, et al.
Publicado: (2022)

Alterations of gyrA, gyrB, and parC and Activity of Efflux Pump in Fluoroquinolone-resistant Acinetobacter baumannii
por: Park, Sunok, et al.
Publicado: (2011)

Fluoroquinolone Resistance Linked to GyrA, GyrB, and ParC Mutations in Salmonella enterica Typhimurium Isolates in Humans
por: Casin, Isabelle, et al.
Publicado: (2003)

Key drug-targeting genes in pancreatic ductal adenocarcinoma
por: Sakharkar, Meena Kishore, et al.
Publicado: (2021)

Therapeutic Implications of Targeting Energy Metabolism in Breast Cancer
por: Sakharkar, Meena K., et al.
Publicado: (2013)

Identification of the likely translational start of Mycobacterium tuberculosis GyrB
por: Karkare, Shantanu, et al.
Publicado: (2013)

Coffee component hydroxyl hydroquinone (HHQ) as a putative ligand for PPAR gamma and implications in breast cancer
por: Shashni, Babita, et al.
Publicado: (2013)

Retraction Note to: Coffee component hydroxyl hydroquinone (HHQ) as a putative ligand for PPAR gamma and implications in breast cancer
por: Shashni, Babita, et al.
Publicado: (2022)

Pairwise correlation of genes involved in glucose metabolism: a potential diagnostic marker of cancer?
por: Sakharkar, Meena Kishore, et al.
Publicado: (2021)

New Insights into Fluoroquinolone Resistance in Mycobacterium tuberculosis: Functional Genetic Analysis of gyrA and gyrB Mutations
por: Malik, Seidu, et al.
Publicado: (2012)

Gene Pair Correlation Coefficients in Sphingolipid Metabolic Pathway as a Potential Prognostic Biomarker for Breast Cancer
por: Sakharkar, Meena Kishore, et al.
Publicado: (2020)

Mutations in gyrB play an important role in ciprofloxacin-resistant Pseudomonas aeruginosa
por: Feng, Xinyuan, et al.
Publicado: (2019)

Prevalence of fluoroquinolone resistance and mutations in the gyrA, parC and parE genes of Riemerella anatipestifer isolated from ducks in China
por: Zhu, Dekang, et al.
Publicado: (2019)

Activity of Chitosans in combination with antibiotics in Pseudomonas aeruginosa
por: Tin, San, et al.
Publicado: (2009)

Alteration in Gene Pair Correlations in Tryptophan Metabolism as a Hallmark in Cancer Diagnosis
por: Sakharkar, Meena Kishore, et al.
Publicado: (2020)

A novel gyrB gene mutation in fluoroquinolone resistant clinical isolates of Mycobacterium tuberculosis
por: Singh, Pooja, et al.
Publicado: (2014)

Frequency and Geographic Distribution of gyrA and gyrB Mutations Associated with Fluoroquinolone Resistance in Clinical Mycobacterium Tuberculosis Isolates: A Systematic Review
por: Avalos, Elisea, et al.
Publicado: (2015)

The dimer state of GyrB is an active form: implications for the initial complex assembly and processive strand passage
por: Wu, Jinjun, et al.
Publicado: (2011)

Role of core promoter sequences in the mechanism of swarmer cell-specific silencing of gyrB transcription in Caulobacter crescentus
por: England, Jennifer C, et al.
Publicado: (2005)

Multiplex gyrB PCR Assay for Identification of Acinetobacter baumannii Is Validated by Whole Genome Sequence-Based Assays
por: Albert, M. John, et al.
Publicado: (2022)

A combined computational-experimental analyses of selected metabolic enzymes in Pseudomonas species
por: Perumal, Deepak, et al.
Publicado: (2008)

Human genomic diversity, viral genomics and proteomics, as exemplified by human papillomaviruses and H5N1 influenza viruses
por: Sakharkar, Meena K, et al.
Publicado: (2009)

Phytochemicals as alternatives to antibiotics against major pathogens involved in bovine respiratory disease(BRD)and bovine mastitis(BM)
por: Rajamanickam, Karthic, et al.
Publicado: (2019)

A Novel Antimicrobial–Phytochemical Conjugate With Antimicrobial Activity Against Streptococcus uberis, Enterococcus faecium, and Enterococcus faecalis
por: Rajamanickam, Karthic, et al.
Publicado: (2019)

A Novel Oligonucleotide Pair for Genotyping Members of the Pseudomonas Genus by Single-Round PCR Amplification of the gyrB Gene
por: Agaras, Betina Cecilia, et al.
Publicado: (2018)

Repeated Exposure of Escherichia coli to High Ciprofloxacin Concentrations Selects gyrB Mutants That Show Fluoroquinolone-Specific Hyperpersistence
por: Perault, Aurore, et al.
Publicado: (2022)

Quantitative analysis on the characteristics of targets with FDA approved drugs
por: Sakharkar, Meena K., et al.
Publicado: (2007)

T-Epitope Designer: A HLA-peptide binding prediction server
por: Kangueane, Pandjassarame, et al.
Publicado: (2005)

Genome SEGE: A database for 'intronless' genes in eukaryotic genomes
por: Sakharkar, Meena Kishore, et al.
Publicado: (2004)

A systems biology approach towards the identification of candidate therapeutic genes and potential biomarkers for Parkinson’s disease
por: Sakharkar, Meena Kishore, et al.
Publicado: (2019)

Alterations in Gene Pair Correlations as Potential Diagnostic Markers for Colon Cancer
por: Yang, Bonnie Yang, et al.
Publicado: (2022)

A domain insertion in Escherichia coli GyrB adopts a novel fold that plays a critical role in gyrase function
por: Schoeffler, Allyn J., et al.
Publicado: (2010)

Gallic Acid Potentiates the Antimicrobial Activity of Tulathromycin Against Two Key Bovine Respiratory Disease (BRD) Causing-Pathogens
por: Rajamanickam, Karthic, et al.
Publicado: (2019)

Characterization of non-classical quinolone resistance in Salmonella enterica serovar Typhi: Report of a novel mutation in gyrB gene and diagnostic challenges
por: Gupta, Ruchi, et al.
Publicado: (2015)

A Comparative Study of Metabolic Network Topology between a Pathogenic and a Non-Pathogenic Bacterium for Potential Drug Target Identification
por: Perumal, Deepak, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_p4u3rhl0s3jffc2v30t9mcs0fj